重复内镜黏膜下剥离术作为初始内镜黏膜下剥离术后食管鳞状细胞癌局部复发的挽救治疗
该回顾性研究纳入中山医院2011年1月至2020年1月间43例患者共45处局部复发性浅表食管鳞状细胞癌病灶行重复内镜黏膜下剥离术,并与909处首次内镜黏膜下剥离术病灶进行倾向性评分匹配(1:2)。重复内镜黏膜下剥离术组完全切除率(86.7% vs 97.8%,P = .02)较低,手术时间(54.8 ± 21.7分钟 vs 46.2 ± 20.6分钟,P = .67)和住院时间(4.3 ± 1.8天 vs 2.9 ± 1.4天,P = .25)较长,整块切除率(93.3% vs 98.8%,P > .11)相当,不良事件无差异。重复内镜黏膜下剥离术5年总生存率和无复发生存率分别为100%和86.0%,多发病灶与重复内镜黏膜下剥离术后复发显著相关(P = .01)。
要点
- 重复内镜黏膜下剥离术治疗局部复发性浅表食管鳞状细胞癌完全切除率为86.7%,低于匹配的首次内镜黏膜下剥离术的97.8%(P = .02)。
- 重复内镜黏膜下剥离术5年总生存率和无复发生存率分别为100%和86.0%。
- 多发病灶与重复内镜黏膜下剥离术后复发显著相关(P = .01)。
核心结论
- 重复食管内镜黏膜下剥离术显示出良好的短期和长期结局,为复发性浅表食管鳞状细胞癌提供了替代选择。
研究设计与样本
- 回顾性纳入中山医院2011年1月至2020年1月间43例患者共45处局部复发性浅表食管鳞状细胞癌病灶行重复内镜黏膜下剥离术,以及909处首次内镜黏膜下剥离术病灶,进行倾向性评分匹配(1:2)后比较重复内镜黏膜下剥离术与首次内镜黏膜下剥离术的手术相关参数。
主要发现
- 与倾向性评分匹配的首次内镜黏膜下剥离术相比,重复内镜黏膜下剥离术组完全切除率较低(86.7% vs 97.8%,P = .02),治愈性切除率较低(86.7% vs 96.7%,P = .06)。
- 重复内镜黏膜下剥离术组手术时间(54.8 ± 21.7分钟 vs 46.2 ± 20.6分钟,P = .67)和住院时间(4.3 ± 1.8天 vs 2.9 ± 1.4天,P = .25)较长。
- 整块切除率(93.3% vs 98.8%,P > .11)在两组间相当。
- 不良事件包括出血(4.4% vs 0%,P = .11)、穿孔(.0% vs .0%,P > .99)和狭窄(6.7% vs 2.2%,P = .33)在两组间无差异。
- 重复内镜黏膜下剥离术的5年总生存率和无复发生存率分别为100%和86.0%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Local recurrence of esophageal squamous cell carcinoma (ESCC) after endoscopic resection does not have an established treatment. The efficacy and safety of repeat endoscopic submucosal dissection (ESD) for recurrent ESCC were determined in the study. METHODS: Forty-three consecutive patients with 45 locally recurrent superficial ESCC lesions undergoing repeat ESD and 909 first ESD lesions for propensity score matching (PSM) at Zhongshan Hospital between January 2011 and January 2020 were retrospectively enrolled. After PSM (1:2), operation-related parameters were compared between repeat ESD and first ESD. In the repeat ESD group, the Kaplan-Meier method and log-rank tests were used for identification of risk factors for local recurrence after repeat ESD. RESULTS: As compared with propensity score-matched first ESD, rates of complete resection (86.7% vs 97.8%, P = .02) and curative resection (86.7% vs 96.7%, P = .06) were lower and procedure duration (54.8 ± 21.7 minutes vs 46.2 ± 20.6 minutes, P = .67) and hospital stay (4.3 ± 1.8 days vs 2.9 ± 1.4 days, P = .25) were longer in the repeat ESD group. The en-bloc resection rate (93.3% vs 98.8%, P > .11) remained comparable. Adverse events including bleeding (4.4% vs 0%, P = .11), perforation (.0% vs .0%, P > .99), and stricture (6.7% vs 2.2%, P = .33) presented with no difference. The 5-year overall survival rate and recurrence-free survival rate for repeat ESD was 100% and 86.0%, respectively. Multiplicity was significantly associated with recurrence after repeat ESD (P = .01). CONCLUSIONS: Repeat esophageal ESD showed favorable short- and long-term outcomes and thus provides an alternative choice for recurrent superficial ESCC.
引用
- Xu JQ, Zhang ZC, Chen WF, et al. Repeat endoscopic submucosal dissection as salvage treatment for local recurrence of esophageal squamous cell carcinoma after initial endoscopic submucosal dissection. Gastrointest Endosc. 2022. PMID: 35240119. doi:10.1016/j.gie.2022.02.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。